ASR Insurances and KLP are among the limited partners in Forbion IV, which will invest in biopharmaceutical companies across Europe and North America.
Netherlands-based venture capital firm Forbion Capital Partners closed a €360 ($415m) fund on Monday with commitments from insurance providers ASR Insurances and KLP, beating its original target of $290m.
TNO Pension Fund, owned by the Netherlands Organisation for Applied Scientific Research, also contributed capital, as did German state-owned development bank KfW and the European Union-owned European Investment Fund (EIF).
The fund’s limited partners also included wealth management firm Formuesforvaltning, private equity firm Pantheon Ventures and a range of undisclosed institutional investors…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
